NEW: Taxpayers and charities helped develop Zolgensma. Then it debuted at a record price, ushering in a new class of wildly expensive drugs.
Its story upends the widely held conception that high prices reflect huge industry investments in innovation.
Its story upends the widely held conception that high prices reflect huge industry investments in innovation.
Comments
Only difference is the logarithmic increase in cost, which is a bold move.
Brian Kaspar might love his $9 million estate, but I don't see how he can sleep at night.
Except for the Gaynors, pretty much everyone involved is a greedy bloodsucker.
Katie Porter already exposed the predatory pricing of NIH funded medications and therapies 2 or 3 years ago during a congressional hearing
white board and all
just that they are slow to do so
But rather than have an "I saw this first" contest, we should be happy that people KEEP reporting about it. More and more people see it, and maybe, fuck forbid, someone will do something.
There zero desire to save us.
https://archive.org/details/isbn_0919573266